Research map: NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution

Back to the article

Papers in this map

  1. Research hotspot and frontier analysis of traditional Chinese medicine in asthma using bibliometric methods from 1991 to 2021 · Yanjiao Chen · 2022 · 9 citations · Cited by this paper
  2. Tislelizumab combined with Anti-GD2 antibody-based chemoimmunotherapy for pediatric relapsed/refractory high-risk neuroblastoma: a two-Case Report · 2026 · Related
  3. Hospital-based health technology assessment: The next frontier for traditional Chinese medicine hospitals · Zeqi Dai · 2021 · 3 citations · Cited by this paper
  4. Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development · 2026 · Related
  5. 从国家自然科学基金看我国各省市基础研究竞争力 · Tingcan Ma · 2011 · 2 citations · Cited by this paper
  6. A nomogram based on LASSO-logistic regression for predicting tocilizumab-associated hypofibrinogenemia in patients with rheumatic diseases · 2026 · Related
  7. Analysis of projects funded by NSFC in field of Chinese materia medica resource in recent three years · Wei Gao · 2016 · 2 citations · Cited by this paper
  8. Traditional Chinese medicine interventions targeting Wnt/β-catenin signaling in cerebral ischemia/reperfusion injury: a review · 2026 · Related
  9. Applications and approved projects on traditional Chinese medicine in National Natural Science Foundation of China in 2010 · Hongcai Shang · 2011 · 1 citation · Cited by this paper
  10. Endothelial EPAS1 as a prognostic and therapeutic target in acute myocardial infarction: integrative bioinformatics, Mendelian randomization and experimental validation · 2026 · Related
  11. Analysis of hot spots and trend of molecular pharmacognosy research based on project supported by National Natural Science Foundation of 1995-2014 · Junwen Wang · 2014 · 1 citation · Cited by this paper
  12. Hematopoietic and T-lymphopoiesis-stimulating effects of a fluorinated pyrazolopiperidine β-cyclodextrin complex in cyclophosphamide-induced hematopoietic suppression · 2026 · Related
  13. [Research progress in nano-delivery systems of active ingredients in TCM for treating kidney diseases]. · Zheng Chen · 2026 · 1 citation · Cited by this paper
  14. Ganhai Weikang Capsules ameliorate functional dyspepsia in rats by modulating gut microbiota and host metabolic homeostasis · 2026 · Related
  15. Therapeutic potential of traditional Chinese medicine for hyperuricemia: mechanistic insights and clinical prospects · 2026 · Related
  16. Exercise-induced myokine irisin protects against obesity-associated ischemic stroke via integrin αVβ5 signaling · 2026 · Related
  17. Therapeutic effect of Yupingfeng powder and its bioactive metabolites on renal diseases · 2026 · Related

Source: OpenAlex (CC0)